These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities. Subsequen...
Tag: Diagnostic/Therapeutic Devices
GE set to report final pre-breakup earnings
General Electric Co. is scheduled to report next week its final quarterly results before the start of its breakup, with the industrial conglomerate expected to report its highest profit since before t...
GE Healthcare will join S&P 500 as soon as it begins trading
GE Healthcare Technologies Inc. will be an S&P 500 stock as soon as it officially exists. General Electric Co. GE, -1.05% expects to spin off its healthcare arm into a separately traded company on...
GE Healthcare Plans to Reduce Debt and Costs, Pursue Tuck-In Acquisitions
General Electric Co.’s healthcare division plans to cut debt, bring down costs and pursue tuck-in acquisitions after its spinoff in early January, finance chief Helmut Zodl said Thursday at an investo...
Bausch + Lomb, Year’s Second-Biggest IPO, Pops in Public Debut
Text size Bausch + Lomb’s IPO is the second-biggest so far this year. Scott Olson/Getty Images Eye-care company Bausch + Lomb and biotech PepGen kicked off their lives as public companies Friday...